Reporting from The Center Square
FDA sets March deadline for abortion pill safety review
(The Center Square) − The U.S. Food and Drug Administration expects to complete a sweeping safety review of the abortion pill mifepristone by March 2027, according to a new federal court filing in Louisiana, potentially setting the stage for restrictions on how the drug is prescribed and distributed nationwide.
Continue reading →





